Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Anticounterfeiting Policy: Pilot Programs Will Not Trigger Enforcement

Executive Summary

FDA will participate in developing anticounterfeiting standards with interested parties, Senior Advisor for Medical & Health Policy Paul Rudolf, MD, said

You may also be interested in...



Pfizer To Begin Tagging All U.S. Viagra Shipments With RFID Chips By Dec. 15

Pfizer will start shipping all Viagra (sildenafil) for the U.S. market with radio frequency identification tags embedded at the case and individual item levels

Pfizer To Begin Tagging All U.S. Viagra Shipments With RFID Chips By Dec. 15

Pfizer will start shipping all Viagra (sildenafil) for the U.S. market with radio frequency identification tags embedded at the case and individual item levels

Rx Electronic Pedigree Program On Track, FDA Says; PhRMA Skeptical

FDA's plan to implement a prescription drug electronic pedigree system by 2007 is "overly optimistic," the Pharmaceutical Research & Manufacturers of America says in a May 12 "white paper.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel